KEGG   PATHWAY: mpah04115
Entry
mpah04115                   Pathway                                
Name
p53 signaling pathway - Mus pahari (shrew mouse)
Description
p53 activation is induced by a number of stress signals, including DNA damage, oxidative stress and activated oncogenes. The p53 protein is employed as a transcriptional activator of p53-regulated genes. This results in three major outputs; cell cycle arrest, cellular senescence or apoptosis. Other p53-regulated gene functions communicate with adjacent cells, repair the damaged DNA or set up positive and negative feedback loops that enhance or attenuate the functions of the p53 protein and integrate these stress responses with other signal transduction pathways.
Class
Cellular Processes; Cell growth and death
Pathway map
mpah04115  p53 signaling pathway
mpah04115

Organism
Mus pahari (shrew mouse) [GN:mpah]
Gene
110312812  Pten; phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN [KO:K01110] [EC:3.1.3.16 3.1.3.48 3.1.3.67]
110312870  Chek2; serine/threonine-protein kinase Chk2 isoform X1 [KO:K06641] [EC:2.7.11.1]
110313068  Serpine1; plasminogen activator inhibitor 1 [KO:K03982]
110313835  [KO:K04506] [EC:2.3.2.27]
110315929  Ccnd2; G1/S-specific cyclin-D2 [KO:K10151]
110316223  [KO:K08738]
110316496  Cdk6; cyclin-dependent kinase 6 [KO:K02091] [EC:2.7.11.22]
110316550  Gadd45a; growth arrest and DNA damage-inducible protein GADD45 alpha isoform X1 [KO:K04402]
110316901  Bid; BH3-interacting domain death agonist [KO:K04726]
110317786  [KO:K08738]
110318368  Cd82; CD82 antigen isoform X1 [KO:K06509]
110318630  Bcl2l1; bcl-2-like protein 1 [KO:K04570]
110318673  Rprm; protein reprimo [KO:K10128]
110319023  Thbs1; thrombospondin-1 isoform X1 [KO:K16857]
110319597  Ddb2; DNA damage-binding protein 2 isoform X1 [KO:K10140]
110320030  Bax; apoptosis regulator BAX isoform X1 [KO:K02159]
110320516  Zmat3; zinc finger matrin-type protein 3 isoform X1 [KO:K10137]
110321327  Mdm4; protein Mdm4 isoform X1 [KO:K10127]
110321591  Bcl2; apoptosis regulator Bcl-2 [KO:K02161]
110321675  Casp8; caspase-8 isoform X1 [KO:K04398] [EC:3.4.22.61]
110322120  Steap3; metalloreductase STEAP3 [KO:K10142] [EC:1.16.1.-]
110322336  Gorab; RAB6-interacting golgin [KO:K19748]
110322378  Ccnd1; G1/S-specific cyclin-D1 [KO:K04503]
110322543  Serpinb5; serpin B5 [KO:K10139]
110322641  Rfwd2; E3 ubiquitin-protein ligase RFWD2 isoform X1 [KO:K10143] [EC:2.3.2.27]
110322900  Tp73; tumor protein p73 isoform X1 [KO:K10148]
110322962  Sesn2; sestrin-2 [KO:K20394]
110323236  Pidd1; p53-induced death domain-containing protein 1 [KO:K10130]
110323250  Sfn; 14-3-3 protein sigma [KO:K06644]
110323338  Casp9; caspase-9 isoform X1 [KO:K04399] [EC:3.4.22.62]
110323545  [KO:K06621]
110324083  Ccne1; G1/S-specific cyclin-E1 isoform X1 [KO:K06626]
110324512  Rrm2; ribonucleoside-diphosphate reductase subunit M2 [KO:K10808] [EC:1.17.4.1]
110324548  Siva1; apoptosis regulatory protein Siva isoform X1 [KO:K22744]
110324650  Tp53i3; LOW QUALITY PROTEIN: quinone oxidoreductase PIG3 [KO:K10133] [EC:1.-.-.-]
110325978  Tnfrsf10b; tumor necrosis factor receptor superfamily member 10B [KO:K04722]
110326196  Cdk4; cyclin-dependent kinase 4 [KO:K02089] [EC:2.7.11.22]
110326248  Sesn1; sestrin-1 isoform X1 [KO:K10141]
110326258  Aifm2; apoptosis-inducing factor 2 isoform X1 [KO:K22745]
110326473  Mdm2; E3 ubiquitin-protein ligase Mdm2 isoform X1 [KO:K06643] [EC:2.3.2.27]
110326492  Cdk1; cyclin-dependent kinase 1 isoform X1 [KO:K02087] [EC:2.7.11.22 2.7.11.23]
110326668  Igf1; insulin-like growth factor I isoform X1 [KO:K05459]
110326839  Gadd45b; growth arrest and DNA damage-inducible protein GADD45 beta [KO:K04402]
110326877  Apaf1; apoptotic protease-activating factor 1 isoform X1 [KO:K02084]
110327130  Cdk2; cyclin-dependent kinase 2 isoform X1 [KO:K02206] [EC:2.7.11.22]
110327308  Chek1; serine/threonine-protein kinase Chk1 isoform X1 [KO:K02216] [EC:2.7.11.1]
110327393  Sesn3; sestrin-3 isoform X1 [KO:K10141]
110327456  Atm; serine-protein kinase ATM isoform X1 [KO:K04728] [EC:2.7.11.1]
110327463  Ccnb2; G2/mitotic-specific cyclin-B2 [KO:K21770]
110327683  Ei24; etoposide-induced protein 2.4 homolog [KO:K10134]
110327731  Shisa5; protein shisa-5 isoform X1 [KO:K10135]
110327928  Atr; serine/threonine-protein kinase ATR isoform X1 [KO:K06640] [EC:2.7.11.1]
110328828  Ccnb1; G2/mitotic-specific cyclin-B1 isoform X1 [KO:K05868]
110330495  Rchy1; RING finger and CHY zinc finger domain-containing protein 1 [KO:K10144] [EC:2.3.2.27]
110330518  Ccng2; cyclin-G2 [KO:K10146]
110330706  Igfbp3; insulin-like growth factor-binding protein 3 isoform X1 [KO:K10138]
110331352  Ccng1; cyclin-G1 [KO:K10145]
110331477  Ppm1d; protein phosphatase 1D isoform X1 [KO:K10147] [EC:3.1.3.16]
110331731  Tp53; cellular tumor antigen p53 isoform X1 [KO:K04451]
110332378  [KO:K08738]
110332797  Fas; tumor necrosis factor receptor superfamily member 6 [KO:K04390]
110333558  Pmaip1; phorbol-12-myristate-13-acetate-induced protein 1 [KO:K10131]
110333844  Gadd45g; growth arrest and DNA damage-inducible protein GADD45 gamma [KO:K04402]
110334609  Znf385a; zinc finger protein 385A isoform X1 [KO:K26543]
110334676  Adgrb1; brain-specific angiogenesis inhibitor 1 [KO:K04596]
110334878  Gtse1; G2 and S phase-expressed protein 1 [KO:K10129]
110334944  Rrm2b; ribonucleoside-diphosphate reductase subunit M2 B isoform X1 [KO:K10808] [EC:1.17.4.1]
110335402  Ccnd3; G1/S-specific cyclin-D3 isoform X1 [KO:K10152]
110336584  Bbc3; bcl-2-binding component 3 [KO:K10132]
110336608  Casp3; caspase-3 [KO:K02187] [EC:3.4.22.56]
110336679  Ppp1r13l; relA-associated inhibitor [KO:K27356]
110337437  Siah1; E3 ubiquitin-protein ligase SIAH1 [KO:K04506] [EC:2.3.2.27]
110338232  Perp; p53 apoptosis effector related to PMP-22 [KO:K10136]
110338236  Cdkn1a; cyclin-dependent kinase inhibitor 1 [KO:K06625]
110338315  Tsc2; tuberin isoform X1 [KO:K07207]
110338930  Ccne2; G1/S-specific cyclin-E2 isoform X1 [KO:K06626]
Reference
  Authors
Levine AJ, Hu W, Feng Z.
  Title
The P53 pathway: what questions remain to be explored?
  Journal
Cell Death Differ 13:1027-36 (2006)
DOI:10.1038/sj.cdd.4401910
Reference
  Authors
Harris SL, Levine AJ.
  Title
The p53 pathway: positive and negative feedback loops.
  Journal
Oncogene 24:2899-908 (2005)
DOI:10.1038/sj.onc.1208615
Reference
  Authors
Balint E E, Vousden KH.
  Title
Activation and activities of the p53 tumour suppressor protein.
  Journal
Br J Cancer 85:1813-23 (2001)
DOI:10.1054/bjoc.2001.2128
Reference
  Authors
Taylor WR, Stark GR.
  Title
Regulation of the G2/M transition by p53.
  Journal
Oncogene 20:1803-15 (2001)
DOI:10.1038/sj.onc.1204252
Reference
  Authors
Hofseth LJ, Hussain SP, Harris CC.
  Title
p53: 25 years after its discovery.
  Journal
Trends Pharmacol Sci 25:177-81 (2004)
DOI:10.1016/j.tips.2004.02.009
Reference
  Authors
Pietenpol JA, Stewart ZA.
  Title
Cell cycle checkpoint signaling: cell cycle arrest versus apoptosis.
  Journal
Toxicology 181-182:475-81 (2002)
DOI:10.1016/S0300-483X(02)00460-2
Reference
  Authors
Tokino T, Nakamura Y.
  Title
The role of p53-target genes in human cancer.
  Journal
Crit Rev Oncol Hematol 33:1-6 (2000)
DOI:10.1016/S1040-8428(99)00051-7
Reference
  Authors
Hermeking H, Benzinger A.
  Title
14-3-3 proteins in cell cycle regulation.
  Journal
Semin Cancer Biol 16:183-92 (2006)
DOI:10.1016/j.semcancer.2006.03.002
Reference
  Authors
Sherr CJ.
  Title
Divorcing ARF and p53: an unsettled case.
  Journal
Nat Rev Cancer 6:663-73 (2006)
DOI:10.1038/nrc1954
Reference
  Authors
Feng Z, Hu W, de Stanchina E, Teresky AK, Jin S, Lowe S, Levine AJ.
  Title
The regulation of AMPK beta1, TSC2, and PTEN expression by p53: stress, cell and tissue specificity, and the role of these gene products in modulating the IGF-1-AKT-mTOR pathways.
  Journal
Cancer Res 67:3043-53 (2007)
DOI:10.1158/0008-5472.CAN-06-4149
Reference
  Authors
Resnick-Silverman L, Manfredi JJ
  Title
Two Faces of SIVA.
  Journal
Cancer Discov 5:581-3 (2015)
DOI:10.1158/2159-8290.CD-15-0484
Reference
  Authors
Resch U, Schichl YM, Winsauer G, Gudi R, Prasad K, de Martin R
  Title
Siva1 is a XIAP-interacting protein that balances NFkappaB and JNK signalling to promote apoptosis.
  Journal
J Cell Sci 122:2651-61 (2009)
DOI:10.1242/jcs.049940
Reference
  Authors
Barkinge JL, Gudi R, Sarah H, Chu F, Borthakur A, Prabhakar BS, Prasad KV
  Title
The p53-induced Siva-1 plays a significant role in cisplatin-mediated apoptosis.
  Journal
J Carcinog 8:2 (2009)
DOI:10.4103/1477-3163.45389
Reference
  Authors
Ohiro Y, Garkavtsev I, Kobayashi S, Sreekumar KR, Nantz R, Higashikubo BT, Duffy SL, Higashikubo R, Usheva A, Gius D, Kley N, Horikoshi N
  Title
A novel p53-inducible apoptogenic gene, PRG3, encodes a homologue of the apoptosis-inducing factor (AIF).
  Journal
FEBS Lett 524:163-71 (2002)
DOI:10.1016/S0014-5793(02)03049-1
Reference
  Authors
Hu Y, Ge W, Wang X, Sutendra G, Zhao K, Dedeic Z, Slee EA, Baer C, Lu X
  Title
Caspase cleavage of iASPP potentiates its ability to inhibit p53 and NF-kappaB.
  Journal
Oncotarget 6:42478-90 (2015)
DOI:10.18632/oncotarget.6478
Related
pathway
mpah04110  Cell cycle
mpah04210  Apoptosis
mpah04218  Cellular senescence
KO pathway
ko04115   

DBGET integrated database retrieval system